| Advanced Enzyme Technologies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540025 |
NSE Symbol : ADVENZYMES |
P/E(TTM) : 28.56 |
|
ISIN Demat : INE837H01020 |
Div & Yield% : 1.66 |
EPS(TTM) : 10.94 |
|
Book Value(₹) : 59.96 |
Market Cap(₹Cr) : 3,496.59 |
Face Value(₹) : 2.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 351.41 | 365.47 | 311.53 | 272.80 | 283.47 |
| Other Income | 61.49 | 58.81 | 9.81 | 9.08 | 6.82 |
| Stock Adjustments | 6.47 | 7.83 | -1.48 | 13.52 | -1.27 |
| Total Income | 419.37 | 432.11 | 319.86 | 295.40 | 289.02 |
| EXPENDITURE : | |||||
| Raw Materials | 148.80 | 139.56 | 121.43 | 112.72 | 95.03 |
| Power and Fuel Cost | 18.52 | 22.73 | 19.58 | 16.19 | 11.53 |
| Other Manufacturing Expenses | 19.94 | 18.57 | 14.52 | 13.53 | 9.25 |
| Selling and Administration Expenses | 38.39 | 33.64 | 32.37 | 28.66 | 28.49 |
| Miscellaneous Expenses | 5.25 | 22.95 | 5.64 | 3.08 | 2.81 |
| Employee Benefit Expenses | 56.04 | 49.39 | 41.42 | 39.32 | 34.23 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 132.44 | 145.28 | 84.89 | 81.90 | 107.67 |
| Interest | 0.51 | 0.39 | 0.33 | 0.27 | 0.24 |
| Gross Profit | 131.93 | 144.89 | 84.56 | 81.63 | 107.43 |
| Depreciation | 11.41 | 10.90 | 10.28 | 9.56 | 9.01 |
| Profit Before Tax | 120.52 | 133.99 | 74.28 | 72.07 | 98.42 |
| Current Tax | 16.89 | 26.95 | 18.25 | 18.02 | 24.84 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.22 | -1.08 | 0.50 | -0.46 | 2.57 |
| Reported Net Profit | 102.42 | 108.12 | 55.53 | 54.51 | 71.01 |
| Extraordinary Items | 0.05 | -15.13 | -0.59 | 0.89 | 0.51 |
| Adjusted Net Profit | 102.37 | 123.25 | 56.12 | 53.62 | 70.50 |
| Adjustment below Net Profit | -0.34 | -0.10 | 0.49 | 0.02 | -0.03 |
| Profit/Loss Balance carried down | 469.61 | 417.50 | 372.66 | 328.19 | 263.91 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 57.03 | 55.91 | 11.18 | 10.06 | 6.70 |
| P & L Balance carried down | 514.66 | 469.61 | 417.50 | 372.66 | 328.19 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 260.00 | 255.00 | 50.00 | 50.00 | 45.00 |
| Dividend Per Share(Rs) | 5.20 | 5.10 | 1.00 | 1.00 | 0.90 |
| Earnings Per Share-Unit Curr | 9.15 | 9.67 | 4.97 | 4.88 | 6.36 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 56.25 | 51.91 | 46.98 | 42.97 | 38.97 |
| Book Value(Adj)-Unit Curr | 56.25 | 51.91 | 46.98 | 42.97 | 38.97 |